| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > Podcasting > Free IPODs: The Truth About Free IPOD Giveaways |
|
Digg It - Free IPODs: The Truth About Free IPOD Giveaways
Have you seen the offers for free IPODs? Run a search on Google, Yahoo, AOL, or any search engine fo According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product r the key word IPOD, and you will be presented with a flurry of offers for free IPODs. With the soar ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ng popularity of free IPODs this offer definitely seems very alluring. After all, who wouldn’t want a lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. free IPOD? The truth about these offers for free IPODs is that there are very clever marketers behin here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe them. These marketers are willing to give you an IPOD for free in exchange for your email address. Y d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ur email address holds allot of value for them. Through your email address they can make offers to yo ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc for various products and offers, which have lucrative pay outs for the marketers. By having you agr easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi e to share your email address they will be able to send you offers withouth being accused of spam. If nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically you decide that you no longer want to receive future offers you simply opt out and the offers will st and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ p coming. But with the price of an IPOD starting at $300, how can those marketers afford to give eve ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi yone a free IPOD simply in exchange for their email address? After all, someone could register and th ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a n opt out right after receiving their free IPOD. In reality the marketers are counting on two import dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod nt goals. They are hoping that a high enough percentage of respondents will participate in the offers cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin they receive, making it worthwhile to run their marketing programs. Second, before giving away the f tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ee IPOD the consumer is required to participate in a few trial offers. Every time the consumer partic t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel pates in a trial offer the marketer is paid. But if a consumer does not fully participate he would no ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust receive the free IPOD. In other words, the free IPOD is only given out when the consumer has taken y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ctions that will compensate the marketer for the free IPOD. This can be a win-win situation for both . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de the consumer and the marketer. The marketer gains by having a consumer participate in trial offers, f elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip r which the marketer is paid, and the consumer gains by having the opportunity to receive a free IPOD tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:A Company That Doesn't Need Public Relations? Like a brick wrapped in velvet - designing a conference presentation (or most other kinds too!) 4 Reasons Why Selling Resell Right Products Are Still Profitable
|